Induced pluripotent stem cells (iPSCs) are derived from adult cells, such as skin or blood cells, which have been “reprogrammed” back to a stem-cell-like state. This transformation grants them the ...
The Daily Galaxy on MSN
Scientists are testing a cellular reset that could push aging human cells back toward youth
Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...
Pluristyx, a leading provider of advanced induced pluripotent stem cell (iPSC) technologies and proprietary, genetically engineered solutions, today announced the Japanese Patent Office (JPO) issued a ...
TAIPEI, June 23, 2026 /PRNewswire/ -- Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's ...
The New York Blood Center Enterprises and the Chan Zuckerberg Biohub are collaborating to derive induced pluripotent stem cell lines from cord blood, using NYBCe’s inventory of over 30,000 units, ...
Efforts to efficiently manufacture human neurons from induced pluripotent stem cells (iPSCs) are rapidly transforming the landscape of neuroscience research, drug discovery, and emerging cell-based ...
Strategic partnership integrates Pluristyx's clinical-grade iPSC platform into Made Scientific's CDMO services, giving developers a single-source path from cell line to commercial supply. PRINCETON, N ...
EPFL researchers have uncovered how transcription factor dosage reshapes cell identity, showing that even small differences in dose can steer cells toward completely different fates. Their findings ...
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results